Minocycline and oral pigmentation

Area of Science:

• Pharmacology
• Dermatology
• Oral Medicine

Background:

• Minocycline is a widely used tetracycline antibiotic for inflammatory acne.
• Its efficacy stems from broad-spectrum activity, reduced resistance, and anti-inflammatory properties.
• Adverse reactions, including skin and oral pigmentation, are noted.

Purpose of the Study:

• To detail the pharmacology of minocycline.
• To describe the occurrence and mechanisms of minocycline-induced pigmentation in oral tissues.
• To inform dental practitioners about early recognition and management.

Main Methods:

• Review of minocycline pharmacology.
• Description of clinical presentation of oral pigmentation.
• Discussion of proposed mechanisms of pigmentation in hard and soft oral tissues.

Main Results:

• Minocycline can cause pigmentation in hard oral tissues, typically presenting as a band on the alveolar mucosa and palate.
• This pigmentation may persist even after drug discontinuation.
• Mechanisms involve drug deposition and potential interactions within oral tissues.

Conclusions:

• Minocycline-induced oral pigmentation is a potential adverse effect.
• Early identification by dental professionals is key to managing aesthetic concerns.
• Prompt recognition allows for consideration of alternative acne treatments to prevent persistent discoloration.